Substituted aryl compound
AssigneesSimcere Pharmaceutical Co., Ltd., Jiangsu Simcere Pharmaceutical Co., Ltd.
InventorsPeng Gu, Lei Liu, Guobao Zhang, Chunyan Zhao, Renhong Tang, Jinsheng Ren
Life of this patent
Estimating the term…
Loading patent…
AssigneesSimcere Pharmaceutical Co., Ltd., Jiangsu Simcere Pharmaceutical Co., Ltd.
InventorsPeng Gu, Lei Liu, Guobao Zhang, Chunyan Zhao, Renhong Tang, Jinsheng Ren
Estimating the term…
The present application describes a substituted aryl compound used as an RAD51 inhibitor and a pharmaceutically acceptable salt thereof. The compound has the structure as represented by Formula (I) and has the substituents and structural features as described in the present application. Furthermore, the present application describes a pharmaceutical composition containing the compound as represented by Formula (I) or the pharmaceutically acceptable salt thereof, and the use of the compound as represented by Formula (I) or the pharmaceutically acceptable salt thereof and the pharmaceutical composition containing same in the preparation of a drug for preventing or treating RAD51 mediated diseases.
A compound represented by formula (I) or a pharmaceutically acceptable salt thereof,
Dependencies are inferred from the claim text.